Sands Capital acquired 1.25M Repligen shares worth $151M. That's 0.44% of their equity portfolio (40th largest holding). The investor owns 2.19% of the outstanding Repligen stock. Sands Capital started to build up the position in Repligen in Q3 2022 and continued to invest until Q4 2022. Since then they sold 530k shares. The investor's estimated purchase price is $261M, resulting in a loss of 42%.
Conestoga Capital Advisors, an asset management company, released its ¡°SMid Cap Growth Strategy¡± third-quarter 2023 investor letter. A copy of the same can b...
https://www.investing.com/news/pro/repligen-corp-receives-investment-bank-analyst-rating-update-3120648
Pulled from Benzinga Pro data, Repligen (NASDAQ: RGEN ) posted Q1 earnings of $28.83 million, an increase from Q4 of 40.84%. Sales dropped to $182.66 million...
https://www.investing.com/news/pro/rbc-capital-starts-repligen-at-sector-perform-432SI-2958584